SCH772984 is primarily used in research settings to study its effects on cancer cell growth and proliferation. It is known to inhibit specific kinases involved in signaling pathways that promote tumor development. Researchers utilize this compound to investigate potential therapeutic strategies for various cancers, particularly those driven by mutations in the MAPK pathway. Its application helps in understanding cellular mechanisms and evaluating its efficacy as a targeted therapy in preclinical models.